Dr. Reddy’s Laboratories Ltd (REDY)

4,409.20
-30.25(-0.68%)
  • Volume:
    396,917
  • Bid/Ask:
    4,409.20/4,414.55
  • Day's Range:
    4,409.20 - 4,480.00

REDY Overview

Prev. Close
4,439.45
Day's Range
4,409.2-4,480
Revenue
237.28B
Open
4,441.95
52 wk Range
3,789.85-4,645
EPS
218.98
Volume
396,917
Market Cap
734.07B
Dividend (Yield)
30.00
(0.69%)
Average Volume (3m)
307,857
P/E Ratio
20.27
Beta
0.241
1-Year Change
10.09%
Shares Outstanding
166,105,115
Next Earnings Date
11 May 2023
What is your sentiment on Dr. Reddy’s Labs?
or
Market is currently closed. Voting is open during market hours.

Dr. Reddy’s Laboratories Ltd Company Profile

Dr. Reddy’s Laboratories Ltd Company Profile

Employees
24795
Market
India
  • Type:Equity
  • Market:India
  • ISIN:INE089A01023
  • S/N:DRREDDY

Dr. Reddy's Laboratories Limited is an India-based pharmaceutical company. The Company’s segments include Global Generics, which is engaged in manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients (PSAI), which is engaged in manufacturing and marketing active pharmaceutical ingredients and intermediates for finished pharmaceutical products; Proprietary Products, which focuses on research and development of differentiated formulations and Others, which consists of the Company’s wholly-owned subsidiary, Aurigene Discovery Technologies Limited, which is a discovery stage biotechnology company developing novel and therapies in the fields of oncology and inflammation.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellBuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyBuy
SummaryStrong SellStrong SellStrong SellStrong BuyStrong Buy